Amneal Pharmaceuticals has introduced its generic Concerta (methylphenidate hydrochloride extended-release) tablets. The drug is indicated to treat attention deficit/hyperactivity disorder as part of a total treatment program.
Amneal’s generic Concerta has begun shipping and is available in 18-, 27-, 36- and 64-mg dosage strengths, all of which are available in 90-count bottles, with 30-count bottles also available.
The product had a U.S. market size of $1.5 billion for the 12 months ended December 2017, according to IQVIA data.
February 5, 2018